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Abstract
Background: As an essential trace element selenium plays a significant role in many physiological functions of the
organs. It is found within muscles as selenocystein in selenoprotein N, which is involved in redox-modulated
calcium homeostasis and in protection against oxidative stress.
Methods: The effects of two different selenium compounds (selenate and NanoSe in 0.5 and 5 ppm concentration
for two weeks) on muscle properties of mice were examined by measuring in vivo muscle performance, in vitro
force in soleus (SOL) and extensor digitorum longus (EDL) muscles and changes in intracellular Ca2+ concentration in
single fibers from flexor digitorum brevis (FDB) muscle.. Western-blot analysis on muscle lysates of EDL and SOL were
used to measure the selenoprotein N expression. Control mice received 0.3 ppm Se.
Results: While the grip force did not change, 5 ppm selenium diets significantly increased the speed of voluntary
running and the daily distance covered. Both forms of selenium increased significantly the amplitude of single
twitches in EDL and SOL muscle in a concentration dependent manner. Selenate increased fatigue resistance in
SOL. The amplitude of the calcium transients evoked by KCl depolarization increased significantly from the control
of 343 ± 44 nM to 671 ± 51 nM in the presence of 0.5 ppm selenate in FDB fibers. In parallel, the rate of calcium
release during short depolarizations increased significantly from 28.4 ± 2.2 to 45.5 ± 3.8 and 52.1 ± 1.9 μM/ms in the
presence of 0.5 ppm NanoSe and selenate, respectively. In 0.5 ppm concentration both selenium compounds
increased significantly the selenoprotein N expression only in EDL muscle.
Conclusions: Selenium supplementation augments calcium release from the sarcoplasmic reticulum thus improves
skeletal muscle performance. These effects are accompanied by the increased selenoprotein N expression in the
muscles which could result in increased oxidative stress tolerance in case of long lasting contraction.
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Background
Significant proportion of locomotor diseases is caused by
muscle weakness or wasting, but the biological mechanisms
involved in these processes are not completely understood.
One potential cause could be the accumulation of nuclear
and mitochondrial DNA damage and increases in oxidative
stress which leads to the loss of muscle fibers and, thus,
decreased functionality of skeletal muscle [1]. Selenium as a
trace element with antioxidant properties plays an import-
ant role in muscle function [2], and associated enzymes as
glutathione reductase and peroxidase protect muscle fibers
from reactive oxygen species [3].
Selenium is a trace mineral needed in small amounts
each day. It is well known for its antioxidant properties
which are responsible for its antiviral and anticancer abil-
ities (for review see [4]), but it is also important for normal
muscle function. Skeletal muscle disorders manifesting in
muscle pain, fatigue, proximal weakness, and serum creat-
ine kinase elevation have been reported in patients with
selenium deficiency [5]. Recent experiments on transgenic
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mice lacking the antioxidant enzyme superoxide dismut-
ase have shown an acceleration of sarcopenia due to
neuromuscular degeneration following mitochondrial
dysfunction. This finding indicates that a decline in the
ability to cope with an increase in oxidative stress may be,
at least in rodents, an important cause of sarcopenia [6].
In ruminant animals, selenium deficiency causes white
muscle disease, the symptoms of which are muscle weak-
ness and degeneration of cardiac and skeletal muscle [7].
Similar human myopathy has also been described [8] and
severe selenium deficiency is associated with skeletal
muscle problems [5].
The recommended daily dietary allowance (RDA) for
selenium according to the European Union is 20–75 μg
for adults and 10–25 μg for children [9]. Unfortunately,
the selenium intake is below the recommended amount in
Europe at present [10]. Therefore, there are extensive ac-
tions to initiate selenium supplementation in the popula-
tion, however, because its toxicity in high concentration
the results are diverse and sometime controversial.
The supplementation of vitamins and elements is very
important and one way to do this is the application of
nanoparticles. They have distinctive properties and exten-
sive application in the healthy diet. Among the various
types of nanoparticles, selenium has good absorption cap-
acity, lower toxicity, high bioavailability and interaction
with proteins [11]. In the past few years a new type of
nano-selenium (NanoSe) was developed as nano sized
elemental selenium particles (between 100 and 500 nm;
[12]). It has lower toxicity and better physiological effects
than inorganic mineral forms of selenium. Recent studies
proved that the toxicity of Se forms decreased in the
following order: selenate > selenite > NanoSe > LactoMi-
croSel® [13, 14]. NanoSe is produced by lactic acid bacteria
(LactoMicroSel® is the same, but made of milk producing
dried yoghurt powder). While selenate is absorbed as is,
NanoSe is transformed into selenite in vivo.
The biological functions of Se are associated with
selenoproteins, a family of proteins which contain this
micronutrient in the form of selenocysteine. The functions
of several selenoproteins have been described, but most of
them have no known functions. Its conservation among
species and their preserved production pathway highlight
the importance of these proteins. Most of those selenopro-
teins whose function is identified are catalytically active in
redox processes. One of them is glutathione peroxidase
(GPx) which plays a role in the catalytic decomposition of
H2O2 into H2O and oxygen. In mammals, there are several
selenocysteine-containing GPx and they modify the oxida-
tion of reduced glutathione (GSH) which is present in
millimolar concentrations in muscle fibers. Nevertheless,
the only selenoprotein implicated so far in a human genetic
disorder associated with skeletal muscles is selenoprotein N
(SelN), encoded by the SEPN1 gene [15] which manifests
in muscle dystrophy. It was shown that SelN is involved in
redox-modulated calcium homeostasis in skeletal muscle
[16] so it could alter the contraction.
Shortening of muscle is a multi-step process called
excitation contraction (EC) coupling. The trigger action
potential traveling along the sarcolemma and the trans-
verse-(T-) tubule membranes activates the calcium release
from the intracellular store (sarcoplasmic reticulum, SR)
via Ca2+ release channels (ryanodine receptor, RyR; [17]).
The voltage sensor/L-type calcium channel in the T-
tubular membrane (dihydropyridine receptor, DHPR; [18])
activates RyR via a direct conformational coupling. The
released calcium ions bind to the regulatory sites on
troponin-C and initiate muscle contraction. During relax-
ation calcium is moved back into the SR via the sarcoplas-
mic calcium pump (SERCA). Since both RyR and SERCA
activity are altered by oxidation, the antioxidant selenium
could have an impact on EC-coupling by modifying intra-
cellular calcium homeostasis.
The specific aim of the present project was to investi-
gate the steps of EC coupling on selenium fed mice and
to understand how its modification leads to the observed
changes in muscle performance.
Methods
Chemicals and selenium sources
Chemicals, unless otherwise stated, were purchased from
Sigma (St. Louis, MO, USA) and were of analytical grade.
Inorganic mineral form of selenate (sodium selenate,
Na2SeO4) and selenite (sodium hydrogen selenite, NaH-
SeO3) were purchased from CEDA Chemicals (Duelmen,
Germany). For producing nano-sized (100 to 500 nm
diameter) elemental selenium (NanoSe) we used the
inorganic selenite dissolved in 5 % MRS Broth bacteria
culture media. The selenite containing media was inocu-
lated with Lactobacillus casei probiotic yoghurt bacteria,
freshly produced from freeze-dried bacteria (three times
re-inoculation). The final concentration of selenium was
200 mg/L. The prepared solution was fermented at 37 °C
in a shaking incubator for 48 h. After the fermentation the
red color of the elemental selenium nano-sized balls pro-
duced by the bacteria can be seen (see Additional file 1:
Figure S1). To extract the pure NanoSe particles we
centrifuged MRS, digested the bacteria pellet with cc.
hydrochloric acid, and washed as well as filtered the cell
debris out. The final NanoSe is a sol (a colloidal suspen-
sion of solid particles with diameter below 500 nm).
Animal care
Animal experiments conformed to the guidelines of the
European Community (86/609/EEC). The experimental
protocol was approved by the institutional Animal Care
Committee of the University of Debrecen (4/2011/DE
MAB). The 25-week-old BDF1 male mice weighing an
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average of 27 g were housed in plastic cages with mesh
covers, and fed with pelleted mouse chow and water ad
libitum. Room illumination was an automated cycle of
12 h light and 12 h dark, and room temperature was
maintained within the range 22–25 °C.
The animal model used was described previously [13].
In brief, inorganic sodium selenate and NanoSe was
administered for 14 days at concentrations of 0.5, and
5 ppm (particle per million) Se, equivalent to 0.5, and
5 mg Se/kg food, corresponding to an estimated 4, and
40 μg/kg body weight/day Se uptake, respectively. The
length of feeding and the applied concentrations were
chosen to minimize toxicity of selenium. Forming lab
diet we minced the pelleted mouse chow and mixed
carefully with the appropriate amount of distillated
water dissolved sodium selenate, as well as homogenized
NanoSe sol. After mixing we granulated and dried the
selenium containing chow again. The concentration of
the NanoSe sol and selenate in the mixed chows was
verified with atomic fluorescence spectrometer after
nitric acid destruction. The control lab diet [19] was
obtained from Charles River (Wilmington, MA, USA)
and it contains sodium selenite. Its 0.3 ppm Se content
was subtracted from the administered Se doses. The
control group received no additional Se besides that of
the basal diet. The number of animals in the groups is
presented in Table 1. Bodyweights of the animals were
measured daily as well as their daily food intake.
Animals were anaesthetized and sacrificed following a
protocol approved by the Animal Care Committee of the
University of Debrecen. After pentobarbital anesthesia
(27 mg/kg), the m. flexor digitorum brevis (FDB), the m.
extensor digitorum longus (EDL) and m. soleus (SOL) from
the hind limb were dissected.
In vivo experiments
Voluntary activity wheel measurement Mice from dif-
ferent groups of treatment were singly housed in a cage
with a mouse running wheel (Campden Instruments Ltd.,
Loughborough, UK). Wheels were interfaced to a computer
and revolutions were recorded in 20 min intervals, continu-
ously for 10 days. The average and the maximal speed, the
distance and the duration of running was calculated for the
individual mice and then averaged by treatments.
Forepaw grip test The force of forepaw was measured
as described earlier [20]. Briefly, when the animals reli-
ably grasped the bar of the grip test meter, they were
then gently pulled away from the device. The maximal
force before the animal released the bar were digitized at
2 kHz and stored by an online connected computer.
In vitro experiments
Measurement of muscle force Muscle contractions
were measured as described in our previous reports [21].
In brief, fast and slow twitch muscles, EDL and SOL,
were removed and placed horizontally in an experimen-
tal chamber continuously super fused (10 ml/min) with
Krebs’ solution (containing in mM: NaCl 135, KCl 5,
CaCl2 2.5, MgSO4 1, Hepes 10, glucose 10, NaHCO3 10;
pH 7.2; room temperature) equilibrated with 95 % O2
plus 5 % CO2. One end of the muscle was attached to a
rod while the other to a capacitive mechano-electric
force transducer. Two platinum electrodes placed adja-
cent to the muscle were used to deliver short, supramax-
imal pulses of 2 ms in duration to elicit single twitches.
Force responses were digitized at 2 kHz using Digidata
1200 A/D card and stored with Axotape software (Axon
Instruments, Foster City, CA, USA). Muscles were then
stretched by adjusting the position of the transducer to a
length that produced the maximal force response and
allowed to equilibrate for 60 min.
Single pulses at 0.5 Hz were used to elicit single
twitches. At least 10 twitches were measured under these
conditions from every muscle. The individual force tran-
sients within such a train varied by less than 3 % in ampli-
tude, thus the mean of the amplitude of all transients was
used to characterize the given muscle. To elicit a tetanus,
Table 1 Body weight changes, muscle/body weights and cross sectional areas
Control (10) Selenate NanoSe
0.5 ppm (6) 5 ppm (8) 0.5 ppm (6) 5 ppm (4)
Body weight change (g) 0.6 ± 0.2 2.3 ± 0.2* 3.6 ± 0.3* 2.5 ± 0.3* 1.3 ± 0.3*
Muscle/body weight (%) EDL 0.038 ± 0.003 (14) 0.050 ± 0.01# (11) 0.045 ± 0.001 (10) 0.051 ± 0.001# (10) 0.049 ± 0.001# (7)
SOL 0.038 ± 0.001 (10) 0.056 ± 0.002# (12) 0.046 ± 0.002# (15) 0.056 ± 0.001# (10) 0.049 ± 0.004# (7)
Cross sectional area (mm2) EDL 1.75 ± 0.13 1.95 ± 0.16 1.87 ± 0.11 1.84 ± 0.13 1.58 ± 0.15
SOL 1.49 ± 0.13 1.54 ± 0.79 1.25 ± 0.06 1.68 ± 0.20 1.24 ± 0.11
*denotes significant increase (P < 0.05) compared to the starting body weight
#denotes significant difference (P < 0.05) compared to control
Numbers in parenthesis denote the number of animals or muscles
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single pulses were applied with a frequency of 200 Hz for
200 ms (EDL) or 100 Hz for 500 ms (SOL). Duration of
individual twitches and tetani were determined by
calculating the time between the onset of the transient
and the relaxation to 90 % of maximal force.
Isolation of single skeletal muscle fibers All calcium
concentration measurements were carried out on skeletal
muscle fibers from the FDB muscle of the mouse. Calcium
free Tyrode’s solution (145 mM NaCl, 2.7 mM KCl, 1 mM
MgCl2, and 11.8 mM Hepes, pH 7.4) was used during the
dissection of the muscle. Single muscle fibers from FDB
were enzymatically dissociated in minimal essential media
containing 0.2 % Type I collagenase (Sigma) at 37 °C for
65 min [22, 23]. To release single fibers, the FDB muscles
were triturated gently in normal Tyrode’s solution
(1.8 mM CaCl2). The fibers were then placed in culture
dishes and stored at 4 °C in refrigerator until use.
Whole cell intracellular Ca2+ concentration measure-
ment Intracellular Ca2+ concentration ([Ca2+]i) was moni-
tored using Fura-2 in acetoxymethyl form as described
previously [22, 24]. Briefly, isolated FDB fibers were
mounted on a laminin-coated cover slip and loaded with
5 μM Fura-2 AM for 60 min. Fibers were then equilibrated
in Tyrode’s solution for 30 min at room temperature. Cover
slips with Fura-2 loaded fibers were placed on the stage of
an inverted fluorescence microscope (Diapoth, Nikon,
Tokyo, Japan). The excitation wavelength was altered
between 340 and 380 nm by a microcomputer-controlled
dual-wavelength monochromator (Deltascan, Photon Tech-
nology International, New Brunswick, NJ), whereas the
emission was monitored at 510 nm using a photomultiplier
at 10 Hz acquisition rate of the ratios at 22 °C. Ca2+-
transients were evoked by KCl depolarization. Fibers were
permanently washed with Tyrode’s solution using a back-
ground perfusion system, whilst the depolarizing solution
(120 mM NaCl was replaced by 120 mM KCl) was applied
through a local perfusion system, which was positioned in
close proximity to the measured fiber. Intracellular calcium
concentration was calculated from the ratio of measured
fluorescence intensities at 340 and 380 nm using an in vivo
calibration as described in our earlier report [22].
Confocal intracellular Ca2+ concentration measure-
ment Changes in [Ca2+]i were also monitored using Rhod-
2 AM as described previously [20]. Briefly, after dissoci-
ation, FDB fibers were placed into culture dish with
Tyrode’s solution. Depolarization-evoked calcium tran-
sients were measured at 22 °C using a confocal laser
scanning microscope system (Zeiss 5 Live, Oberkochen,
Germany) after loading the fibers with 20 μM Rhod-2 AM
for 15 min at room temperature. Individual action poten-
tials were evoked by applying supra-threshold 2 ms long
square pulses (S88 Stimulator, Grass Technologies, War-
wick, RI, USA) through a pair of platinum electrodes
placed close to the fiber. Line-scan images (512 pixels/line)
were used to monitor the fluorescence intensity changes at
1 ms/line and using a 40x water immersion objective.
Rhod-2 was excited with a HeNe ion laser at 543 nm,
emission was detected with a 550 nm long pass filter. To
obtain the time-course of Rhod-2 fluorescence change
(Frhod), corresponding data points (usually 10–15) in the
line-scan images were averaged in the spatial domain.
Resting fluorescence was determined as the average
fluorescence before the depolarization. Changes in [Ca2+]i
were then calculated using the formula
Ca2þ
 
i ¼ Kdrhod• 1=koff ; rhod• dFrhod=dt þ Frhod– Frhod;min
 
= Frhod;max– Frhod
 
ð1Þ
where Frhod,max and Frhod,min were determined in our
laboratory, while other parameters (Kdrhod = koff,rhod /
kon,rhod is the dissociation constant, koff,rhod and kon,rhod
the backward and forward rate constant for the calcium-
dye reaction, respectively) for Rhod-2 were taken from
Escobar and co-workers [25].
Calculation of calcium release from the SR The Ca2+
release flux (FL) was defined as the first time derivative
of the sum of the Ca2+ in the myoplasmic space and that
transported back into the SR, as described earlier:
FL ¼ d Catotal þ Catransp
 
= dt; ð2Þ
where Catotal is the total Ca
2+ in the myoplasm, while
Catransp is the amount of Ca
2+ transported by the Ca2+
pumps [15]. Catotal was estimated as the sum of free Ca
2+
and the amount of Ca2+ bound to intracellular binding sites.
In Eq. 2. Catransp was considered proportional to the
relative saturation of the pumps. Removal parameters
were taken from the literature [26] and used to calculate
the binding of Ca2+ to intracellular binding sites as
described in our earlier reports [27].
Preparation of cell extracts Freshly prepared EDL and
soleus muscles were mechanically homogenized in buffer
(20 mM Tris–Cl, 5 mM EGTA, 1 mM 4-(2-aminoethyl)
benzenesulphonyl fluoride, 20 μM leupeptin, pH 7.4; all
from Sigma) and disrupted by sonication on ice. Protein
content of the samples was measured by a modified
bicinchoninic acid (BCA) protein assay (Pierce, Rockford,
IL, USA) using BSA as a standard.
Western blot analysis For Western blot analysis (SDS–
PAGE) total muscle lysates of EDL and SOL were prepared
by adding 1/5 volume of fivefold concentrated electrophor-
esis sample buffer (310 mM Trise-HCl pH 6.8, 10 % SDS,
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50 % glycerol, 100 mM DTT, 0.01 % bromophenol blue) to
muscle lysates and boiled for 10 min at 80 C. 30 μg of
protein was separated by 7.5 % SDS–PAGE gel for im-
munological detection of selenoprotein N. Proteins were
transferred electrophoretically to nitrocellulose membranes.
After blocking in 5 % non-fat dry milk in PBS, membranes
were incubated with primary antibodies overnight at 4 °C
as follows: rabbit polyclonal anti-selenoprotein N antibody
raised against amino acids 293–452 mapping within an in-
ternal region of selenoprotein N of human origin in 1:200,
(Santa Cruz Biotechnology, INC, Santa Cruz, CA, USA);
and rabbit polyclonal anti-actin antibody in 1:500 (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA). After
washing for 30 min in PBST, membranes were incubated
with the HRP-conjugated secondary antibody (Bio-Rad,
Hercules, CA, USA) in 1:1000 dilution in PBS
containing 5 % non-fat dry milk for 1 h. Signals were
detected by enhanced chemiluminescence reaction
(Millipore, Billerica, MA, USA) according to the in-
structions of the manufacturer.
Statistical analysis Pooled data were expressed as mean
± standard error of the mean (SEM). The differences be-
tween control and animals on increased selenium diet were
assessed using one way analysis of variance (ANOVA) and
all pair wise multiple comparison procedures (Student-
Newman-Keuls Method) with Prism (GraphPad Software,
San Diego, CA, USA). F-test was used to test the signifi-
cance and a P value of less than 0.05 was considered statis-
tically significant.
Results
In vivo experiments
Mice on selenium supplemented diet gained weight dur-
ing the two weeks of Se-feeding while control animals
remained almost the same weight (Table 1). To check the
in vivo muscle performance of the animals, 4 mice were
used from all groups (control, 0.5 and 5 ppm selenate and
NanoSe) in grip tests. Mice from selenium-treated groups
did not perform significantly better than the control
animals in these tests. That is, the maximal force after
normalization to body weight remained the same after
14 days on selenium diet (Table 2).
The voluntary wheel experiments showed a positive
effect of selenium treatment on the performance of
animals, but only in the higher (5 ppm) concentration.
After 2–3 days accommodation in the special cage the
average and maximal speed of running stabilized on a
given level in the control group, while they increased
continuously in the 5 ppm selenium treated mice (Fig. 1).
The total distance covered was significantly higher in the
5 ppm selenium feed groups (Table 3). In addition, they
spent more time in the wheel than control mice did at the
end of 5 ppm selenium supplementation. Overall, this
experiment clearly indicated, that there is a positive effect
on voluntary muscle performance of selenium treatment
in mice. To clarify the underlying mechanisms the steps
in EC coupling were investigated in detail.
In vitro experiments
Force measurement
In order to determine whether administration of selen-
ium might alter muscle functions directly, the effects of
selenium supplementation on in vitro muscle strength
were investigated. A significant difference was found in
Table 2 Maximal grip force (mN) at the beginning and at the
end of experiment
Control (4) Selenate NanoSe
0.5 ppm (4) 5 ppm (4) 0.5 ppm (4) 5 ppm (4)
Beginninga 507 ± 19 534 ± 9 455 ± 9 493 ± 17 571 ± 8
Enda 504 ± 16 509 ± 7 474 ± 14 502 ± 11 553 ± 9
Numbers in parenthesis denote the number of animals. aAverage of values
measured on the first and last day of 14 days special diet
Fig. 1 Speed of voluntary running increased after selenium
treatment. Average (a) and maximal (b) speed of animals during
voluntary running. After 3 days the speeds stabilized in the control
group due to their accommodation to the experimental conditions
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the mean amplitude of the single twitches in both EDL
(Fig. 2a,b) and in SOL (Fig. 3a,b) between selenium
supplemented and the control animals (Table 4). Simi-
larly, significant difference was found in tetani (Figs. 2c,d
and 3c,d). In lower concentration of selenium (0.5 ppm)
the average amplitude of twitches and tetani was signifi-
cantly higher than in control conditions only in SOL.
There were no differences in the twitch/tetanus ratio
between the selenium supplemented and the control
muscles (data not shown). There was no difference in
the time-to-peak values except in SOL of the 0.5 ppm
selenate treated animals, where it was significantly
higher than in control mice. Furthermore, selenate
increased fatigue resistance in SOL after 150 tetani (see
Table 3 Parameters of voluntary running at the beginning and at the end of experiment
Control (8) Selenate NanoSe
0.5 ppm (8) 5 ppm (8) 0.5 ppm (8) 5 ppm (8)
Distance (m/day) Beginninga 5313 ± 406 5280 ± 548 4959 ± 226 5343 ± 699 4994 ± 301
Enda 4592 ± 354 4910 ± 1056 6642 ± 168##,** 5178 ± 612 7820 ± 851#,*
Duration (min/day) Beginninga 334 ± 16 306 ± 17 315 ± 10 339 ± 17 335 ± 16
Enda 253 ± 10** 264 ± 43 302 ± 4##,* 268 ± 26* 333 ± 17##
Average speed (m/min) Beginninga 11.3 ± 1.1 12.5 ± 0.8 13.6 ± 1.2 11.7 ± 0.5 13.2 ± 1.1
Enda 12.0 ± 0.5 13.9 ± 0.7# 21.4 ± 0.1###,** 14.7 ± 0.3##,** 21.1 ± 0.8###,**
Maximal speed (m/min) Beginninga 20.8 ± 0.9 23.2 ± 0.9 22.1 ± 1.7 20.5 ± 1.6 23.8 ± 1.8
Enda 21.2 ± 0.4 23.3 ± 1.3 32.1 ± 0.6###,** 23.2 ± 1.1 33.8 ± 1.3###,**
#, ## and ### denotes significant difference (P < 0.05, 0.01 and 0.001) compared to control
* and ** denotes significant difference (P < 0.05 and 0.01) compared to beginning
Numbers in parenthesis denote the number of animals
aAverage of values measured on the first three and last three day of 10 days special diet
Fig. 2 Isometric force was higher in EDL muscle of selenium treated mice. Representative twitch force (a, b) and tetanus (c, d) at two different
NanoSe (a, c) and selenate (b, d) concentrations on EDL muscle at room temperature (24 °C). The force was normalized to the cross section area
of the muscle
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Additional file 1: Figure S2). In addition, we observed a
significant increase in all but one relative EDL and SOL
muscle weight (Table 1).
Intracellular Ca2+ concentration changes after selenium
treatment
The effects of the selenium treatments on the calcium
homeostasis were examined in isolated, single FDB
skeletal muscle fibers. Figure 4a presents representative
calcium transients evoked by depolarization using
120 mM KCl in the presence of normal (1.8 mM) extra-
cellular calcium concentration. Selenium already in
0.5 ppm concentration increased the amplitude of cal-
cium transients. Figure 4b plots pooled data to confirm
that the selenium treatment had a little, but statistically
significant increasing effects on the resting [Ca2+]i sug-
gesting that the calcium leak from and the extrusion into
the extracellular environment could be affected under
these conditions. On the other hand, depolarization-
evoked calcium transients were notably higher in
selenium treated than in control fibers (Fig. 4c). Selenate
almost doubled the amplitude of the calcium transients.
The same concentration of NanoSe also increased it
slightly, albeit this increase was not as pronounced.
Further examination of the transients proved that the
rate of calcium release from the SR was significantly
higher after both kinds of selenium treatments (Fig. 4d).
Action potential-evoked calcium transients in FDB fibers
Field stimulation-induced global calcium transients were
also measured on FDB fibers. These calcium transients
were visualized using laser scanning confocal microscopy in
the line-scan mode. Figure 5 displays representative fluores-
cence intensity changes during single pulses (panel A) from
control (left), 0.5 ppm selenate (middle) and NanoSe (right)
treated mice. The spatial profile of the transients was
homogenous in all groups showing a normal propagation
of the depolarization in the T-tubular system.
To analyze the calcium transients, the line-scans were
normalized to background fluorescence and 10–15 points
of the images in the spatial domain were averaged and
transformed to calcium concentration (Eq. 1). Then the
total amount of calcium released (Catotal) and the calcium
release flux (FL) through the RyRs was calculated (Eq. 2).
It is clearly visible in Fig. 5, that the change in intracellular
calcium concentration (panel B and D) as well as the total
calcium released into the myoplasm (panel E), and the
corresponding calcium release flux (panel F) was
Fig. 3 Isometric force of SOL muscle was higher in selenium treated mice. Representative twitch force (a, b) and tetanus (c, d) at two different
NanoSe (a, c) and selenate (b, d) concentrations on SOL muscle at room temperature (24 °C)
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Table 4 Average parameters of twitch and tetanus of EDL and soleus muscles
Contraction
type
Control Selenate NanoSe
0.5 ppm 5 ppm 0.5 ppm 5 ppm
EDL SOL EDL SOL EDL SOL EDL SOL EDL SOL
Peak
(mN/mm2)
Single twitch 0.72 ± 0.09 0.52 ± 0.10 0.68 ± 0.11 0.93 ± 0.13* 0.98 ± 0.08* 1.06 ± 0.15* 0.82 ± 0.13 1.04 ± 0.20* 0.96 ± 0.08* 1.26 ± 0.12*
Tetanus 2.55 ± 0.39 2.72 ± 0.41 2.81 ± 0.09 5.72 ± 0.73* 3.81 ± 0.46* 6.46 ± 0.90* 3.29 ± 0.44 5.36 ± 1.31* 3.97 ± 0.56* 7.12 ± 0.37*
Time to
peak (ms)
Single twitch 26.7 ± 2.0 63.5 ± 4.1 28.9 ± 1.6 68.4 ± 3.2 30.0 ± 1.3 68.2 ± 2.7 29.4 ± 1.5 65.7 ± 3.4 27.9 ± 0.73 69.4 ± 7.5
Tetanus 142.2 ± 15.6 475.2 ± 21.2 140.1 ± 25.6 530.5 ± 4.2* 144.1 ± 10.6 458.4 ± 45.2 128.1 ± 14.4 475.5 ± 49.9 147.2 ± 12.6 493.3 ± 27.8
Fatigue after
150 tetani (%)
31.8 ± 5.4 29.5 ± 2.7 38.8 ± 10.5 43.3 ± 3.9 41.1 ± 3.6 47.5 ± 5.6 42.9 ± 3.2 45.7 ± 6.2 43.9 ± 6.3 49.7 ± 8.0
Number of
muscles
tested
Single twitch 14 10 11 12 14 15 10 10 7 7
Tetanus 14 15 5 8 14 11 8 8 5 6
*denotes significant difference (P < 0.05) compared to control. The amplitude of the 150th tetani were normalized to the first tetanus
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increased significantly in selenate treated mice. The
amount of released calcium showed an about 60 and
100 % increase in 0.5 ppm NanoSe and selenate fed mice,
respectively. The data presented in Fig. 5 clearly demon-
strate that depolarization-evoked calcium release from the
SR was significantly higher in selenium fed mice.
Western blot analysis of selenoprotein expression
Finally the expression level of selenoprotein N in EDL
and SOL muscles from control mice and mice fed with
NanoSe or selenate was determined. In 0.5 ppm concen-
tration both selenium compounds increased significantly
the SelN expression only in EDL muscle (Fig. 6a and b).
However, in 5 ppm concentration both selenium com-
pounds increased SelN expression significantly in both
(EDL and SOL) muscle samples (data not shown).
Discussion
The results of our study provide novel insights into the
effects of dietary selenium on skeletal muscle functions.
New findings of the study are the direct effects of selen-
ium supplementation on skeletal muscle function.
Selenoprotein in selenium fed animals
One explanation of the increased force we observed on
the selenium fed mice could be the alteration of the
expression of selenoprotein N. Arbogast and Ferreiro [16]
have shown that SelN deficiency is associated with
abnormalities in intracellular Ca2+ handling, potentially
related with RyR1 dysfunction in myotubes. Another study
on rats presented that the lack of selenoprotein causes
diaphragm muscle weakness by lowering diaphragmatic
glutathione peroxidase activity, and then these ani-
mals are subjected to the oxidative stress of resistive
loading [28].
We examined the selenoprotein N expression of mus-
cles and found it markedly increased in EDL (Fig. 6). This
is in good agreement with previous studies [29, 30], where
selenium supplementation caused a similar increase in the
level of several selenoproteins. In our experiments a low
dose of selenium produced favorable effects on skeletal
Fig. 4 Selenium treatment augmented KCl depolarization evoked Ca2+ transients and resting [Ca2+]i in FDB fibers. Depolarization evoked changes in
intracellular calcium concentration in FDB muscle (a) of control (left), 0.5 ppm NanoSe (middle) and 0.5 ppm selenate (right) feed mice. Average values
of resting [Ca2+]i (b), change in [Ca
2+]i (Δ[Ca
2+]i) (c) and maximal rate of rise of the transients (d). Numbers in parenthesis give the number of fibers
investigated. * and *** denote significant difference from control at levels of P < 0.05 and P < 0.001, respectively
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muscle functions, presumably by increasing the intracellu-
lar availability of selenium for selenoprotein N synthesis
and stimulating SelN expression.
Toxicity and efficacy
Several animal studies showed long time ago that Se
deficiency may result in damage to the heart, liver,
kidneys, lung and skeletal muscle [7, 29, 31, 32]. On the
contrary, only recent investigations aimed to explore the
effects of increased Se supplementation [13, 14, 29, 30],
but none of them studied skeletal muscle functions. The
doses used in our study (0.5 and 5 mg/kg) were similar to
doses used in a previous study [13] in which both were
shown not to be toxic in mice. Though in this study both
selenium compounds decreased the white blood cell num-
ber and the weight of spleen in the higher concentration,
only selenate decreased the weight of liver. These changes
were significant but did not lead to the death of animals.
Fig. 5 Depolarization evoked Δ[Ca2+]i and release flux were higher in FDB fibers of selenium treated mice. Line-scan images of fluorescence intensity
changes evoked by single depolarization (a) in FDB of control (left), 0.5 ppm NanoSe (middle) and 0.5 ppm selenate (right) feed mice. Intracellular calcium
concentration changes (b) calculated from the Ca2+ transient in panel (a). The corresponding calcium release flux through the RyR (c) calculated from
the curves in panel (b). The averages of the change in intracellular calcium concentration (d), the total calcium released into the myoplasm (e), and the
corresponding calcium release flux (f). ** and *** show significant difference from control at levels of P< 0.01 and P< 0.001, respectively. Numbers in
parenthesis give the number of fibers investigated. Measurement conditions: 8000x50 pixel, 0.5 μs/line, 0.66 μm/pixel at room temperature (24 °C)
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We point out that all animals survived the 2-week-long
treatment in our experiments and a minor increase in
body weight was observed proving the sub toxic dose of
selenium. On the other hand, the higher Se dose (5 mg/
kg) caused significant decrease in body weight of rats, but
not in mice after 14 days [33]. However, a 12 weeks appli-
cation of 0.5 mg/kg sodium selenite induced reactive myo-
cardial fibrosis and systolic dysfunction in mice [29]. This
suggest that there is a narrow range between the effective
and toxic concentration of selenium and its accumulation
needs also to be considered in further therapy.
We did not find obvious difference in the efficacy of the
two selenium compounds. In in vivo experiments they were
equally effective. NanoSe increased more the force in EDL
than selenate, however their efficacy was the same in soleus.
This can be explained considering the fact that NanoSe
increased the SelN expression in EDL more than selenate,
whereas this effect was equal in the slow muscle.
Surprisingly selenate increased more the amplitude of
calcium release from the SR. Similar bipolar effects were
observed in a recent study [34] where the efficacy and tox-
icity of selenium nanoparticles and selenium dioxide were
compared. Whereas the former showed higher scavenging
activity and lower cytotoxicity in cell culture, the latter had
higher electron-donating activity.
Regulation of EC-coupling
It has been known for a long time that muscular activity in-
creases the production of reactive oxygen species, and this
seems to correlate with the loss of muscle function [35–
37]. Exogenous antioxidants given prior to the onset of
muscle activity, delay or minimize the decline in muscle
performance and decrease the effects of the oxidative stress
[37, 38]. However, the relationship between the function of
the different cellular antioxidant systems and the perform-
ance of skeletal muscles remains unclear. It was shown re-
cently that reactive oxygen species is a physiological
regulator of skeletal RyR [39]. Oxidation of RyR resulted in
increased RyR activity and Ca2+ leak from the sarcoplasmic
reticulum in rest. This leads to reduced SR calcium content
and finally decreased force production. The antioxidant ef-
fect of selenium can reverse this and result in a higher force
as observed here. Similar effects were found in a study on
diabetic rats demonstrating a cardio protective action of
selenium and suggesting that one of the underlying mecha-
nisms is the protection of cardiac ryanodine receptor Ca2+
release channel against oxidative stress [40].
SelN can also regulate the calcium level in the SR via
enhancing SERCA activity by reducing the luminal
H2O2-oxidized cysteines [41]. This is clearly visible in
Fig. 5b showing the faster declining phase (i.e. higher
pumping rate of SERCA) after depolarization in case of
both selenium compounds. In the absence of SelN, ex-
cessive oxidation of SERCA results in reduced reuptake
of calcium and an increase of cytosolic calcium at rest.
This again results in a decrease in SR calcium content
and associates with decreased muscle force.
It was also shown in zebrafish embryos that both SelN
and RyR are required for normal muscle development.
These two proteins are physically associated in vivo and
SelN is necessary for full activation of RyR [42]. Our
observation that Se supplementation increased the SelN
level may also explain the increased intracellular calcium
concentration change during depolarization. Combining its
antioxidant effects on EC-coupling components with the
latter the result could be an improved force production of
skeletal muscle.
The effects of selenium on muscle performance
Several studies investigated the effects of selenium supple-
mentation on body weights in chickens [43], lambs [44],
Fig. 6 Selenoprotein N expression increased in selenium treated
mice. Representative Western blot image showing the expression of
selenoprotein N in EDL and SOL muscles from a control mouse and
a mouse fed with 0.5 ppm NanoSe or selenate for two weeks (a).
Actin was used as loading control. Quantified expression of
selenoprotein N in EDL and SOL muscles of selenium treated mice
normalized to actin and control (b). * denotes significant difference
from control at level P < 0.05. Numbers in parenthesis give the
number of animals fed with 0.5 ppm NanoSe or selenate
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cows [45], and also in laboratory animals like rats [46] and
mice [13]. The results are diverse depending on the con-
centration, duration, and source of selenium. We found a
slight but significant body weight and relative muscle
weight increase in our experiments. This is in good agree-
ment with a recent study in which fish oil and selenium
supplementation was able to increase body and muscle
weight in pathological conditions [47]. The authors gave a
plausible explanation that the supplementation of selenium
and fish oil improved the skeletal muscle atrophy due to
down-regulation of myostatin and related cytokines. This
pathway can work also in control condition and it is known
that the inhibition of myostatin leads to extraordinary in-
crease in muscle weight [20].
Even though selenium is widely used as dietary supple-
ment alone or in combination with vitamins, its effects on
muscle performance is under-investigated. Up to now only
one clinical trial was conducted on humans [48]. In this
study vitamin E, vitamin C, zinc, and selenium supplemen-
tation for 17 weeks improved maximal voluntary contrac-
tion, and endurance limit time of quadriceps by reducing
oxidative stress and enhancing the antioxidant defenses.
We found similar positive effects on force in EDL and SOL
of mice just after 2 weeks application of selenium alone. Al-
though, the whole muscle experiments were done on EDL
and SOL, while isolated muscle fiber experiments were on
FDB the results are reconcilable, since EDL and FDB
contains essentially only fast-twitch fibers. The higher
intracellular [Ca2+] change during depolarization in
FDB fibers from Se supplemented mice is well corre-
lated with the higher force development in EDL from
the same animal. The fact that the human study was
conducted on Facioscapulohumeral muscular dys-
trophy patients, underline the potential application of
selenium in medical treatment.
Conclusion
In conclusion, selenium has positive effects on the muscle
performance of mice and NanoSe takes its effects already in
low concentration. It increases the releasable calcium in the
intracellular stores and the selenoprotein N expression in
the muscles. Our results suggest that an antioxidant strategy
with a low dose selenium supplementation could be a rele-
vant therapeutic approach for patients with myopathies and
could also serve as counteracting sarcopenia in the elderly.
Additional file
Additional file 1: Figure S1. Photo of bacterias (B) and elemental
selenium nanoparticles (globular objects with 200-500 nm diameter) by
scanning electron microscope. The elemental selenium nano-sized balls
(NanoSe) have red color in truth. Figure S2 150 tetani were elicited at 0.5
Hz during 5 min. The amplitude of tetani was normalized to the first
tetanus. (PDF 280 kb)
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